scholarly journals Efficacy of Diabetes Education in Adults With Diabetes Mellitus Type 2 in Primary Care: A Systematic Review

2020 ◽  
Vol 52 (2) ◽  
pp. 155-163
Author(s):  
Celia Cruz‐Cobo ◽  
M José Santi‐Cano
Cureus ◽  
2021 ◽  
Author(s):  
Ioannis Papaioannou ◽  
Georgia Pantazidou ◽  
Zinon Kokkalis ◽  
Neoklis Georgopoulos ◽  
Eleni Jelastopulu

2021 ◽  
Vol 9 (17) ◽  
pp. 28-35
Author(s):  
Aldo Pelcastre Neri ◽  
Vanessa C. de Carranza-Ayala

Introduction. Despite the efforts to provide care for people with type 2 diabetes by conducting multiple intervention studies to educate people with diabetes mellitus, work still needs to be done to include the family as a strategy to improve disease control. Objective. A systematical review was made with the objective of analyzing educational interventions, implemented in adult people with diabetes mellitus type 2 in Mexico, including their family. Materials and Methods. Bibliographic search was made in CrossRef, Medline (PubMed), EBSCO, SCIELO and UAEH digital library. Results. From the nine articles found, seven mention the importance of the family receiving diabetes education. However, none of them mention the family in educational sessions as part of comprehensive management. Three articles mention the economic impact to the family as an out-of-pocket expense. Conclusions. Educational interventions in diabetes significantly improve the metabolic control of people with diabetes mellitus type 2, however, in Mexico there is no evidence of the inclusion of the family in such interventions, whose importance lies as support within the family system.


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Justin T. Call ◽  
Pedro Cortés ◽  
Dana M. Harris

Abstract The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).


2015 ◽  
Vol 16 (1) ◽  
Author(s):  
Loraine Busetto ◽  
Katrien Ger Luijkx ◽  
Arianne Mathilda Josephus Elissen ◽  
Hubertus Johannes Maria Vrijhoef

Sign in / Sign up

Export Citation Format

Share Document